News Conference News TCT 2020 Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19 Todd Neale October 14, 2020
News Conference News TCT 2020 Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI Todd Neale October 14, 2020
News Daily News Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors Shelley Wood September 30, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Daily News PCI Volumes Rise in US and Japan, but for Different Reasons Michael O'Riordan September 14, 2020
News Conference News ESC 2020 More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART Yael L. Maxwell September 08, 2020
News Conference News ESC 2020 Acute MI Patients With Anemia May Require Fewer RBC Transfusions: REALITY Caitlin E. Cox September 01, 2020
News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Daily News Premature CV Death Is Not Declining Fast Enough: National Data L.A. McKeown July 31, 2020
News Daily News Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients Todd Neale July 21, 2020
News Conference News SCCT 2020 ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT Yael L. Maxwell July 20, 2020
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Conference News EuroPCR 2020 Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients Michael O'Riordan June 30, 2020
News Daily News Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients Michael O'Riordan June 10, 2020
News Daily News More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California Shelley Wood May 22, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020